New York City—June 28, 2010
“Public health data indicate that the prevalence, impact, and economic consequences of osteoarthritis are expected to rise dramatically within the next several decades. Clearly, understanding and preventing this disease is an urgent research challenge,” said
Steven Goldring, M.D., chief scientific officer at Hospital for Special Surgery and co-director of the conference. Timothy Wright, Ph.D., Kirby Chair of Orthopedic Biomechanics at HSS, is also a co-director of the event.
Hospital for Special Surgery is at the forefront of the national movement focused on elevating awareness of OA as well as the research, patient care, and innovation necessary to improve the outcomes in patients suffering from osteoarthritis.
Osteoarthritis (OA) is one of the most urgent health care challenges of our time, affecting 27 million Americans.
About Hospital for Special Surgery
Hospital for Special Surgery (HSS) is the world’s leading academic medical center focused on musculoskeletal health. HSS is nationally ranked No. 1 in orthopedics and No. 3 in rheumatology by U.S. News & World Report (2017-2018), and is the first hospital in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. HSS has one of the lowest infection rates in the country. HSS is an affiliate of Weill Cornell Medical College and as such all Hospital for Special Surgery medical staff are faculty of Weill Cornell. The hospital's research division is internationally recognized as a leader in the investigation of musculoskeletal and autoimmune diseases. HSS has locations in New York, New Jersey and Connecticut.